Search results
Pfizer-Connect Biopharma deal for inflammatory drug ends
Seeking Alpha· 6 hours agoConnect Biopharma (CNTB) terminates licensing deal with Pfizer (PFE) for CBP-174, an oral...
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
FierceBiotech· 13 hours agoPfizer’s cost cuts that began last year have stretched to the closure of a well-known internal R&D...
Connect Biopharma uncouples from Pfizer by scrapping long-standing eczema pact
FierceBiotech· 13 hours agoConnect Biopharma is uncoupling from Pfizer, returning the rights to an eczema candidate it picked...
Canaan hires Pfizer executive, reels in $100M for biotech investing
BioPharma Dive via Yahoo Finance· 14 hours agoThe firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist...
Lee Howard: What's Going On: Pfizer putting $20 million-plus into local renovations
The Day· 3 days agoFILE- A Pfizer logo is shown at their global supply Kalamazoo manufacturing plant in Portage, Mich.,...
Pfizer (NYSE:PFE) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 21 hours agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued on Monday, Benzinga ...
VC firm Canaan adds $100M-plus for biotech bets and tacks on a Pfizer vet to gauge early science
FierceBiotech· 13 hours agoGeneral Partner Julie Grant told Fierce Biotech that the money will act as a designated pool for...
Pfizer Inc. (NYSE:PFE) Shares Sold by Vontobel Holding Ltd.
ETF DAILY NEWS· 2 days agoVontobel Holding Ltd. lowered its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 27.0% in the fourth quarter, according to the company in its most recent filing ...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 5 days ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
New Insider Trading Precedent: Time To Update Insider Trading Policy | JD Supra
JD Supra· 7 hours agoThe SEC’s complaint alleged that Panuwat used highly confidential information of his employer, Medivation, Inc.’s (“Medivation”) upcoming acquisition by Pfizer Inc. (“< ...